Ahmad Masri, MD, MS

home / authors / ahmad-masri

Ahmad Masri, MD, MS, is the director of the Hypertrophic Cardiomyopathy Center at Oregon Health and Science University.

Articles

Ahmad Masri, MD, MS | Credit: Oregon Health and Science University

Open-Label Study Finds Aficamten Could Help Most oHCM Patients Avoid Surgery

Ahmad Masri, MD, MS;Patrick Campbell
November 21st 2024

Ahmad Masri, MD, MS, discusses data from the FOREST-HCM trial examining effects of aficamten in patients with oHCM eligible for septal reduction therapy at baseline.

Read More

Ahmad Masri, MD, MS | Credit: Oregon Health and Science University

Recent Advances Have Improved Prognosis in ATTR-CM Patients, with Ahmad Masri, MD, MS

Ahmad Masri, MD, MS;Patrick Campbell
November 21st 2024

Ahmad Masri, MD, MS, discusses a study from AHA 2024 detailing changing risk profiles and outcomes in trials among patients with ATTR-CM.

Read More

Latest Updated Articles

Gursimran Kochhar, MD | Credit: Allegheny Health Network
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
HCPLive Cardiology Month in Review: April 2024
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Published: November 16th 2024 | Updated: December 22nd 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Published: November 15th 2024 | Updated: December 22nd 2024
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Scott Bartley, MD I Credit: LinkedIn
Published: December 16th 2024 | Updated: December 22nd 2024
Brilaroxazine Shows Long-Term Efficacy in Schizophrenia in Phase 3 RECOVER
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
Published: December 16th 2024 | Updated: December 22nd 2024
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
© 2024 MJH Life Sciences

All rights reserved.